Bird Flu Market Revenue Report with Forecast to 2031

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bird Flu Market - (By Virus Type (H5N1, H7N9, H5N6, H5N8, H10N8, H9N2, Others), By Test Type (PCR Tests, ELISA Tests, Hemagglutination Assays, Virus Isolation Tests, Next Generation Sequencing, Others), By Treatment Type (Vaccines, Antiviral Medication, Immunomodulators, Others), By Animal Type (Chickens, Ducks, Geese & Swans, Pigeons, Guinea Fowls, Turkeys, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Bird Flu Market is valued at US$ 1.41 Bn in 2023, and it is expected to reach US$ 2.17 Bn by 2031, with a CAGR of 5.82% during the forecast period of 2024-2031.

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2347

Bird flu or Avian Influenza mostly affects birds, while it can also infect people and other animals. Bird flu is similar to the influenza viruses that may cause seasonal flu epidemics in people, despite the fact that it is often more virulent in birds. Rising government spending on the creation of more effective treatments and a rise in the number of birds dying globally from different viral illnesses are expected to fuel the growth of the global market for bird flu. The market dynamics of bird flu infection are influenced by factors such as the emergence of new virus strains, changes in poultry farming practices, global trade, and advancements in medical technology. While the direct market related to bird flu in humans may be smaller compared to other diseases due to its relatively rare transmission to humans, the potential for a pandemic and its impact on the poultry industry makes it a significant area of concern for public health and economic stability.

List of Prominent Players in the Bird Flu Market
• Boehringer Ingelheim
• Ceva Santé Animale
• Zoetis
• Merck & Co.
• Ringpu Biology
• Yebio Bioengineering
• FATRO
• CAVAC
• ChengDu Tecbond
• QYH Biotech
• Elanco
• Phibro Animal Health
• Vetoquinol
• Hipra
• Venkys
• Anicon Labor GmbH
• Bioveta
• Lohmann Animal Health
• Biogenesis Bago
• Sanofi
• F. Hoffmann-La Roche Ltd.
• Mallinckrodt
• GlaxoSmithKline plc
• Novartis AG
• Bayer AG
• Eli Lilly and Company
• AstraZeneca
• Johnson & Johnson Private Limited
• Bimeda, Inc.
• Phibro Animal Health Corporation
• Medion
• Other prominent players

Market Dynamics:
Drivers-
The demand for animal protein in the form of pig, chicken, and other meats has significantly expanded over the past few decades due to the world's population expansion, which has been exponential. Animal populations are growing, which has increased the susceptibility of certain animals-particularly chickens and ducks-to viral infections and illnesses. It is recognised that migrating wild birds like ducks, geese, and shorebirds, as well as domestic poultry, contribute to the natural ecology of bird flu viruses. During their periodic migrations, wild birds may go thousands of kilometres, which might possibly spread diseases across great distances. Information from wild bird surveillance is useful for developing strategies for managing diseases and assessing risks.

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2347

Challenges:
One key difficulty is that societal opposition impedes control methods. Farmers lose a lot of money when huge numbers of birds are culled during epidemics. Some groups oppose mass population reduction because they believe it will negatively impact their way of life. They could also be sceptical about immunisations and other forms of control. Sometimes, false information feeds prejudice. It is particularly difficult to track the origins of outbreaks when live poultry is moved widely and illegally, especially in wet markets. This problem can be made worse by society's lack of collaboration. One of the main things holding back the bird flu market's expansion is the high expense of developing vaccines. The process of creating a new vaccination is costly and requires a lot of testing, clinical trials, regulatory clearances, and research.

Regional Trends:
When it comes to preferred regions, North America has gained the lead. Based in the United States are many notable firms that manufacture diagnostics and vaccinations against avian influenza. Because of the vast chicken markets in both the US and Canada, North America has emerged as a leader in the planning and prevention of epidemics. Commercial poultry farms must heavily apply biosecurity measures due to strict food safety standards.
Furthermore, the region with the quickest rate of growth for bird flu prevention and control is Asia Pacific. China, India, and Vietnam are among the nations with the highest production and consumption of chicken. This increases the likelihood that avian influenza epidemics caused by migrating wild birds will occur.

Recent Developments:
•In July 2023, The vaccination campaign scheduled to commence in October 2023 in France chosen Boehringer Ingelheim, a German company, to supply the required quantity of 80 million doses of avian influenza vaccines. By commencing this campaign, France achieved the distinction of being the inaugural member state of the European Union to immunize poultry against avian influenza. Positive test results for vaccines manufactured in France by Ceva Animal Health and Boehringer Ingelheim were reported by officials of the Ministry of Agriculture last month.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/2347

Segmentation of Bird Flu Market -
By Virus Type:
• H5N1
• H7N9
• H5N6
• H5N8
• H10N8
• H9N2
• Others
By Test Type:
• PCR Tests
• ELISA Tests
• Hemagglutination Assays
• Virus Isolation Tests
• Next Generation Sequencing
• Others
By Treatment Type:
• Vaccines
• Antiviral Medication
• Immunomodulators
• Others
By Animal Type:
• Chickens
• Ducks
• Geese & Swans
• Pigeons
• Guinea Fowls
• Turkeys
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Get more information:@ https://www.insightaceanalytic.com/customisation/2347

Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.